Explore All 282 Stake Purchase Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | March 16, 2022 |
| Target | NonExomics |
| Sector | Life Science |
| Investor(s) | Illumina |
| Deal Type | Stake Purchase |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 10,590 |
| Revenue | 4.4B USD (2024) |
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. Illumina was formed in 1998 and is based in San Diego, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 22 of 31 |
| Sector: Life Science | 12 of 20 |
| Type: Stake Purchase | 7 of 14 |
| State: Massachusetts | 1 of 2 |
| Country: United States | 18 of 22 |
| Year: 2022 | 7 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-03-16 |
Rethink Bio
Pune, India Rethink Bio is a synthetic biology company focused on harnessing the potential of microalgae to develop sustainable food solutions to benefit the planet and people. Rethink Bio was founded in 2020 and is based in Pune, India. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-09-14 |
Dama Health
London, United Kingdom Dama Health is a women's health company that offers precision screening to identify the most suitable contraception type and formulation, empowering women, people assigned to females at birth, and clinicians to make personalized reproductive health decisions. Dama Health is based in London, United Kingdom. |
Buy | - |
